Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis

2011 ◽  
Vol 165 (5) ◽  
pp. 1087-1094 ◽  
Author(s):  
C. Bodemer ◽  
E. Bourrat ◽  
J. Mazereeuw-Hautier ◽  
F. Boralevi ◽  
S. Barbarot ◽  
...  
Keyword(s):  
Medium Term ◽  
Term Efficacy ◽  
Inherited Ichthyosis

W1324 Medium Term Efficacy, Mucosal Healing and Safety of Adalimumab Therapy in Patients With Crohn's Disease. National Data From Hungary

2010 ◽  
Vol 138 (5) ◽  
pp. S-699 ◽  
Author(s):  
Zsofia Czegledi ◽  
Pál Miheller ◽  
Tamas Molnar ◽  
Laszlo Lakatos ◽  
Aron Vincze ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Mucosal Healing ◽  
National Data ◽  
Medium Term ◽  
Term Efficacy ◽  
Adalimumab Therapy

Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis

2012 ◽  
Vol 72 (3) ◽  
pp. 464-465 ◽  
Author(s):  
Markku Hakala ◽  
Kai Immonen ◽  
Markku Korpela ◽  
Mikko Vasala ◽  
Markku J Kauppi
Keyword(s):  
Medium Term ◽  
Term Efficacy ◽  
Reactive Amyloidosis ◽  
Tnf Α ◽  
Good Medium

Sa1976 Predicting Short and Medium-Term Efficacy of the Biosimilar Infliximab: Trough Levels/ADAs or Clinical/Biochemical Markers Play a More Important Role?

2016 ◽  
Vol 150 (4) ◽  
pp. S421-S422
Author(s):  
Petra A. Golovics ◽  
Zsuzsanna Vegh ◽  
Mariann Rutka ◽  
Krisztina Gecse ◽  
Anita Balint ◽  
...  
Keyword(s):  
Biochemical Markers ◽  
Medium Term ◽  
Term Efficacy ◽  
Trough Levels
Sign in / Sign up

Export Citation Format

Share Document